Fair Value Calculator Fair Value Calculator
EN DE

INDOKEM (INDOKEM) Fair Value & Analysis

IN · Market cap ₹13.9B

I INDOKEM INDOKEM · BSE
Price₹498.40
Fair Value₹975.80
Upside+95.8%
Quality52/100
Watch INDOKEM for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹813.96 – ₹1,269

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price −7.1% over the past month.

Price vs Fair Value (12 months)

₹916.65 ₹285.75 Fair Value ₹975.80 Jul 2025 Jul 2026

12‑month range ₹285.75 – ₹916.65 · fair‑value band ₹813.96 – ₹1,269 · the ₹498.40 price screens below the ₹975.80 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

INDOKEM (INDOKEM) currently trades at ₹498.40, while our model-based Fair Value estimate is ₹975.80 — implying the stock looks roughly 95.8% undervalued today. We read business quality at 52/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, INDOKEM generated revenue of ₹1.7B at a net margin of 1.1%. Revenue declined 16.5% year over year. It earns a return on equity of 2.9%. Net debt stands at ₹240M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹813.96 (bear case) to ₹1,269 (bull case); at ₹498.40, the current price sits below that range. The share trades about 46% below its 52-week high and 78% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.7B
Revenue growth (YoY) -16.5%
Net margin 1.1%
Return on equity 2.9%
Free cash flow −₹73.5M FY2025
P/E ratio 722.3
More key figures
Operating margin 2.2%
EPS (TTM) ₹0.6900
EPS growth (YoY) -90.4%
Net debt ₹240M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

INDOKEM reported revenue of ₹1.7B in FY2025 versus ₹1.1B in FY2021, a compound +10.5%/yr. Reported net income was ₹18.7M in FY2025, compounding −9.8%/yr from FY2021.

Revenue +10.5%/yr
FY21 ₹1.1B
FY22 ₹1.6B
FY23 ₹1.6B
FY24 ₹1.8B
FY25 ₹1.7B
Net income −9.8%/yr
FY21 ₹28.3M
FY22 −₹13.2M
FY23 −₹62.2M
FY24 ₹31.7M
FY25 ₹18.7M

Is INDOKEM fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "INDOKEM Fair Value". https://www.fairvalue-calculator.com/stock/INDOKEM

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is INDOKEM (INDOKEM) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹975.80 versus a price of ₹498.40 — about +96% (undervalued). Model-based estimate, not financial advice.
What is the fair value of INDOKEM?
Our model-based fair value for INDOKEM is ₹975.80 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹498.40.
What is the quality score of INDOKEM?
INDOKEM has a Quality Score of 52/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of INDOKEM (INDOKEM)?
INDOKEM reported trailing-twelve-month revenue of about ₹1.7B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of INDOKEM?
The net profit margin of INDOKEM is about 1.1%, meaning it keeps roughly 1.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.